Literature DB >> 28529990

Gastric cancer treatment: similarity and difference between China and Korea.

Kun Yang1,2, Jian-Kun Hu1,2.   

Abstract

Chinese populations have many demographic similarities to Korean populations. However, the long-term survival rates of gastric cancer patients in China are still not satisfactory when compared with Korea, especially for the advanced cases. In this article, we discuss about the similarity and difference of gastric cancer treatment in terms of screening, surgical approach, stomach resection, digestive tract reconstruction, lymphadenectomy, harvested lymph nodes, operative morbidity and mortality, postoperative chemotherapy as well as follow-up between China and Korea. Given that a variety of factors ranging from tumor characteristics to different treatment strategies are seen between the two countries, the reasons accounting for the differences in survival should be focused and the corresponding strategy should be considered and finally promote to improve the prognosis of gastric cancer.

Entities:  

Keywords:  China; Gastric cancer; Korea; difference; similarity; treatment

Year:  2017        PMID: 28529990      PMCID: PMC5420517          DOI: 10.21037/tgh.2017.04.02

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  59 in total

1.  Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

2.  Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma: let us move on to another era.

Authors:  Sir Alfred Cuschieri; George B Hanna
Journal:  Ann Surg       Date:  2014-06       Impact factor: 12.969

3.  Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.

Authors:  Yanfeng Hu; Changming Huang; Yihong Sun; Xiangqian Su; Hui Cao; Jiankun Hu; Yingwei Xue; Jian Suo; Kaixiong Tao; Xianli He; Hongbo Wei; Mingang Ying; Weiguo Hu; Xiaohui Du; Pingyan Chen; Hao Liu; Chaohui Zheng; Fenglin Liu; Jiang Yu; Ziyu Li; Gang Zhao; Xinzu Chen; Kuan Wang; Ping Li; Jiadi Xing; Guoxin Li
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

4.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

5.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  Comparison of Billroth I and Billroth II reconstructions after laparoscopy-assisted distal gastrectomy: a retrospective analysis of large-scale multicenter results from Korea.

Authors:  Kyu-Chul Kang; Gyu Seok Cho; Sang Uk Han; Wook Kim; Hyung-Ho Kim; Min-Chan Kim; Woo Jin Hyung; Seong Yeob Ryu; Seung Wan Ryu; Hyuk Joon Lee; Kyo Young Song
Journal:  Surg Endosc       Date:  2010-12-07       Impact factor: 4.584

7.  Learning curve for gastric cancer surgery based on actual survival.

Authors:  Chan Young Kim; Byung-Ho Nam; Gyu Seok Cho; Woo Jin Hyung; Min Chan Kim; Hyuk-Joon Lee; Keun Won Ryu; Sung Wan Ryu; Dong Woo Shin; Jun Ho Lee
Journal:  Gastric Cancer       Date:  2015-02-25       Impact factor: 7.370

Review 8.  Comparing the short-term outcomes of totally intracorporeal gastroduodenostomy with extracorporeal gastroduodenostomy after laparoscopic distal gastrectomy for gastric cancer: a single surgeon's experience and a rapid systematic review with meta-analysis.

Authors:  Deok Gie Kim; Yoon Young Choi; Ji Yeong An; In Gyu Kwon; In Cho; Yoo Min Kim; Jung Min Bae; Myung Gyu Song; Sung Hoon Noh
Journal:  Surg Endosc       Date:  2013-03-14       Impact factor: 4.584

9.  Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients.

Authors:  Oh Jeong; Young-Kyu Park
Journal:  J Gastric Cancer       Date:  2011-06-30       Impact factor: 3.720

10.  Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution.

Authors:  Woo Jin Hyung; Sung Soo Kim; Won Hyuk Choi; Jae Ho Cheong; Seung Ho Choi; Choong Bai Kim; Sung Hoon Noh
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

View more
  10 in total

1.  Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway.

Authors:  Ning Wang; Li-Li Chang
Journal:  Hum Cell       Date:  2020-05-14       Impact factor: 4.174

2.  A modified method for Billroth-II gastrojejunostomy after laparoscopy-assisted distal gastrectomy.

Authors:  Zehui Wu; Bing Wang; Gang Liu; Jiaju Lu; Fangzheng Chen; Lianghui Shi
Journal:  Transl Cancer Res       Date:  2022-04       Impact factor: 0.496

3.  Ultrasonic surgical and electrosurgical system (USES) with conventional ultrasonic scalpel (CUS) in gastrectomy: a retrospective cohort study.

Authors:  Changqing Jing; Yuezhi Chen; Liang Shang; Jinshen Wang; Guodong Lian; Feng Tian; Yixue Shao; Yingnan Zhao; Jianwei Xuan; Leping Li
Journal:  Cost Eff Resour Alloc       Date:  2022-05-07

4.  Jianpi Bushen, a Traditional Chinese Medicine Therapy, Combined with Chemotherapy for Gastric Cancer Treatment: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yunbo Chen; Guijuan Zhang; Xiaoping Chen; Xuefeng Jiang; Fengjie Bie; Naijun Yuan; Yurong Wang; Xiaoqian Hao; Min Ma
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-20       Impact factor: 2.629

5.  Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial.

Authors:  Tianshu Liu; Yanru Qin; Jin Li; Ruihua Xu; Jianming Xu; Shujun Yang; Shukui Qin; Yuxian Bai; Changping Wu; Yixiang Mao; Haiyan Wu; Yilin Ge; Lin Shen
Journal:  Cancer Commun (Lond)       Date:  2019-06-24

6.  Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapy.

Authors:  Jin Wang; Bowen Yang; Zhi Li; Jinglei Qu; Jing Liu; Na Song; Ying Chen; Yu Cheng; Simeng Zhang; Zhongqing Wang; Xiujuan Qu; Yunpeng Liu
Journal:  Ann Transl Med       Date:  2020-03

7.  Effect of Shengbai Decoction on Chemotherapy-Induced Myelosuppression and Survival of Gastric Cancer Patients After Radical Resection: A Retrospective Study.

Authors:  Linhua Yao; Wenming Feng; Yulong Tao; Chengwu Tang
Journal:  Med Sci Monit       Date:  2022-02-21

8.  Detection Rate and Prognosis of Lymph Nodes in Gastric Cancer Using Nano Carbon Combined with In Vitro Anatomical Sorting.

Authors:  Jun Ma; Chongren Ren; Gang Du; Jinxi Wang; Zhenguo Han; Huhu Li; Huiyu Li; Liang Xue
Journal:  Comput Intell Neurosci       Date:  2022-08-23

9.  Primary Investigation of Deep Learning Models for Japanese "Group Classification" of Whole-Slide Images of Gastric Endoscopic Biopsy.

Authors:  Xiaoya Fan; Lihui Yu; Xin Qi; Xue Lin; Junjun Zhao; Dong Wang; Jing Zhang
Journal:  Comput Math Methods Med       Date:  2022-09-26       Impact factor: 2.809

10.  Overexpression of Kin of IRRE-Like Protein 1 (KIRREL) in Gastric Cancer and Its Clinical Prognostic Significance.

Authors:  Ming-Jun Zhang; Yan-Yan Hong; Na Li
Journal:  Med Sci Monit       Date:  2018-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.